Literature DB >> 22899873

A causal framework for surrogate endpoints with semi-competing risks data.

Debashis Ghosh1.   

Abstract

In this note, we address the problem of surrogacy using a causal modelling framework that differs substantially from the potential outcomes model that pervades the biostatistical literature. The framework comes from econometrics and conceptualizes direct effects of the surrogate endpoint on the true endpoint. While this framework can incorporate the so-called semi-competing risks data structure, we also derive a fundamental non-identifiability result. Relationships to existing causal modelling frameworks are also discussed.

Entities:  

Year:  2012        PMID: 22899873      PMCID: PMC3418330          DOI: 10.1016/j.spl.2012.06.010

Source DB:  PubMed          Journal:  Stat Probab Lett        ISSN: 0167-7152            Impact factor:   0.870


  14 in total

1.  Principal stratification in causal inference.

Authors:  Constantine E Frangakis; Donald B Rubin
Journal:  Biometrics       Date:  2002-03       Impact factor: 2.571

Review 2.  Graphical models for causation, and the identification problem.

Authors:  David A Freedman
Journal:  Eval Rev       Date:  2004-08

3.  A nonidentifiability aspect of the problem of competing risks.

Authors:  A Tsiatis
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

4.  Identifiability and exchangeability for direct and indirect effects.

Authors:  J M Robins; S Greenland
Journal:  Epidemiology       Date:  1992-03       Impact factor: 4.822

5.  Counterfactual links to the proportion of treatment effect explained by a surrogate marker.

Authors:  Jeremy M G Taylor; Yue Wang; Rodolphe Thiébaut
Journal:  Biometrics       Date:  2005-12       Impact factor: 2.571

6.  Statistical validation of intermediate endpoints for chronic diseases.

Authors:  L S Freedman; B I Graubard; A Schatzkin
Journal:  Stat Med       Date:  1992-01-30       Impact factor: 2.373

7.  Related causal frameworks for surrogate outcomes.

Authors:  Marshall M Joffe; Tom Greene
Journal:  Biometrics       Date:  2009-06       Impact factor: 2.571

8.  Surrogate endpoints in clinical trials: definition and operational criteria.

Authors:  R L Prentice
Journal:  Stat Med       Date:  1989-04       Impact factor: 2.373

9.  Links between analysis of surrogate endpoints and endogeneity.

Authors:  Debashis Ghosh; Michael R Elliott; Jeremy M G Taylor
Journal:  Stat Med       Date:  2010-12-10       Impact factor: 2.373

10.  A bayesian approach to surrogacy assessment using principal stratification in clinical trials.

Authors:  Yun Li; Jeremy M G Taylor; Michael R Elliott
Journal:  Biometrics       Date:  2009-08-10       Impact factor: 2.571

View more
  1 in total

1.  Covariate adjustment using propensity scores for dependent censoring problems in the accelerated failure time model.

Authors:  Youngjoo Cho; Chen Hu; Debashis Ghosh
Journal:  Stat Med       Date:  2017-10-10       Impact factor: 2.373

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.